You are viewing the site in preview mode

Skip to main content


Figure 1 | Radiation Oncology

Figure 1

From: Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases

Figure 1

Sequential change of T2-weighted MRI (upper column), Gd-enhanced T1-weighted MRI (middle column) and F-BPA-PET (lower column) of Case 1, a 44-year-old male. The timing of the MRIs is depicted above the MRIs. F-BPA-PET images were taken just before the BNCT and at 1 month and 10 months after the BNCT. These PET images show the gradual decrease of the tracer uptake as a promising effect of the BNCT. BV was started 10 months after the BNCT, and the MRI showed marked improvement of both perifocal edema and contrast enhancements by BV treatment.

Back to article page